Completed PHASE4 INTERVENTIONAL 1-arm NCT00167687

Prazosin Alcohol Dependence IVR Study

A Double-Blind Placebo-Controlled Trial of Prazosin for the Treatment of Alcohol Dependence

Sponsor: US Department of Veterans Affairs

Interventions prazosin

Updated 6 times since 2017 Last updated: Feb 13, 2008 Started: Sep 30, 2005 Primary completion: Oct 31, 2007 Completion: Oct 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00167687, this PHASE4 trial focuses on Alcoholism and remains completed. Sponsored by US Department of Veterans Affairs, it has been updated 6 times since 2005, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Aug 2018 — Jan 2021 [monthly]

Completed PHASE4
Jun 2018 — Aug 2018 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Sep 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

US Department of Veterans Affairs
University of Washington

Data source: University of Washington

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seattle, United States